减少IV级新生儿重症监护病房中培养阴性脓毒症的抗生素使用
该质量改进项目在IV级新生儿重症监护病房通过制定抗生素指南、病例审计、每周抗生素管理查房和每两周病例回顾等干预,旨在减少培养阴性脓毒症的抗生素疗程和疗程长度。结果显示培养阴性脓毒症的抗生素治疗天数显著下降81%,主要源于早发型脓毒症治疗天数从18.3降至3.9 DOTs/1000 PDs,总体抗生素治疗天数从232.5降至176.7 DOTs/1000 PDs,且平衡措施无变化。
要点
- 实施病例审计和抗生素管理查房等干预可显著减少培养阴性脓毒症的抗生素使用。
- 培养阴性脓毒症抗生素治疗天数下降81%,主要来自早发型脓毒症治疗天数的减少。
- 总体抗生素治疗天数下降,且抗生素启动、再启动和广谱指数等平衡措施无变化。
核心结论
- 该质量改进项目通过优先病例回顾和管理查房促进指南依从并减少培养阴性脓毒症治疗,使IV级NICU抗生素使用下降。
研究设计与样本
- 采用改进模型与序贯Plan-Do-Study-Act循环在IV级NICU实施干预,纳入接受任何剂量抗生素且无重大先天畸形的所有患者。
- 干预包括制定抗生素指南、病例审计、每周抗生素管理查房和每两周工作人员会议回顾培养阴性脓毒症病例。
- 主要结局指标为每1000患者日的培养阴性脓毒症疗程数和抗生素治疗天数。
- 平衡措施包括抗生素启动事件数、再启动事件数和抗生素谱指数。
主要发现
- 与基线相比,培养阴性脓毒症的抗生素治疗天数显著下降81%。
- 亚组分析显示该变化由早发型脓毒症治疗天数减少驱动,从18.3降至3.9 DOTs/1000 PDs。
- 总体抗生素治疗天数从232.5降至176.7 DOTs/1000 PDs。
- 所有预设平衡措施均无变化。
临床怎么用
- 在NICU中可通过制定抗生素指南、病例审计和管理查房等策略减少培养阴性脓毒症的抗生素使用。
- 应监测抗生素启动、再启动和抗生素谱指数等平衡措施以确保干预安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Antibiotic use for suspected infection without a source occurs frequently in neonatal intensive care units (NICUs). Prolonged antibiotic use is associated with increased risk for late-onset sepsis, death, and emergence of multidrug-resistant bacteria. Our aim was to reduce antibiotic use for culture-negative sepsis (CNS) through interventions designed to decrease the number and length of antibiotic courses for CNS. METHODS: Our team used the Model for Improvement with sequential Plan-Do-Study-Act cycles to implement interventions in our level IV NICU. These included the creation of Antibiotic Guidelines, case audits, weekly antibiotic stewardship rounds, and biweekly review of CNS cases at staff meetings. All patients who received any dose of antibiotic and who had no major congenital anomalies were included. The primary outcome measures were CNS courses and antibiotic days of therapy (DOTs) per 1000 patient days (PDs). We tracked the number of antibiotic initiation events, re-initiation events, and antibiotic spectrum index as balancing measures. RESULTS: Antibiotic DOTs for CNS decreased significantly (81%) compared with baseline after study interventions. Subgroup analysis revealed this change was driven by a decrease in early-onset sepsis DOTs, with a reduction from 18.3 to 3.9 DOTs/1000 PDs. Overall antibiotic DOTs for the unit decreased from 232.5 to 176.7 DOTs/1000 PDs. There was no change in any of the prespecified balancing measures. CONCLUSIONS: This quality-improvement initiative, which prioritized case review and stewardship rounds to promote guideline adherence and reduce the treatment of CNS, resulted in a decrease in antibiotic use in a level IV NICU.
引用
- Lewis JM, Hodo LN, Duchon J, et al. Reducing Antibiotic Use for Culture-Negative Sepsis in a Level IV Neonatal Intensive Care Unit. Pediatrics. 2025. PMID: 39999319. doi:10.1542/peds.2023-065098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。